4//SEC Filing
Liu Wen Tao 4
Accession 0001654954-18-003882
CIK 0001378624other
Filed
Apr 11, 8:00 PM ET
Accepted
Apr 12, 4:05 PM ET
Size
13.8 KB
Accession
0001654954-18-003882
Insider Transaction Report
Form 4
Liu Wen Tao (Steve)
DirectorCEO
Transactions
- Exercise/Conversion
Common Stock
2018-04-10$15.53/sh+10,400$161,512→ 223,476 total - Sale
Common Stock
2018-04-11$20.08/sh−12,044$241,844→ 213,076 total - Exercise/Conversion
Non-Qlfd. Stock Option(right to buy)(2014 Plan-Grant 14-142)
2018-04-10−10,400→ 12,044 totalExercise: $15.53→ Common Stock (10,400 underlying) - Sale
Common Stock
2018-04-10$20.09/sh−10,400$208,988→ 213,076 total - Exercise/Conversion
Common Stock
2018-04-11$15.53/sh+12,044$187,043→ 225,120 total - Exercise/Conversion
Non-Qlfd. Stock Option(right to buy)(2014 Plan-Grant 14-142)
2018-04-11−12,044→ 0 totalExercise: $15.53→ Common Stock (12,044 underlying)
Footnotes (4)
- [F1]The transactions reported were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 25, 2015. Accordingly, the reporting person had no discretion with regard to the timing of the transactions.
- [F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $20.05 to $20.20, inclusive.
- [F3]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $20.00 to $20.40, inclusive.
- [F4]This option vested over a period of three years according to the following schedule: 1/3 on December 31, 2015 and 1/3 on each anniversary thereafter. The expiration date of such option is May 6, 2017 or 3 months after the reporting person ceases serving on the board of directors of the registrant, whichever is later.
Documents
Issuer
Cellular Biomedicine Group, Inc.
CIK 0001378624
Entity typeother
Related Parties
1- filerCIK 0001569874
Filing Metadata
- Form type
- 4
- Filed
- Apr 11, 8:00 PM ET
- Accepted
- Apr 12, 4:05 PM ET
- Size
- 13.8 KB